The absence of any association between NGB accumulation in breast cancer tissues and other estrogen receptors (e.g., ERβ and GPER) strongly sustains the results obtained in cancer cell lines confirming the pivotal involvement of the ERα/AKT pathway in NGB accumulation in breast cancer tissues. The gene discussed is ESR2; the disease is breast cancer.